Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M103,596Revenue $M35,551Net Margin (%)2.5Altman Z-Score1.3
Enterprise Value $M127,460EPS $0.2Operating Margin %7.5Piotroski F-Score4
P/E(ttm)112Beneish M-Score-2.6Pre-tax Margin (%)4.7Higher ROA y-yN
Price/Book25.210-y EBITDA Growth Rate %0.3Quick Ratio0.8Cash flow > EarningsY
Price/Sales2.95-y EBITDA Growth Rate %-5.1Current Ratio1.1Lower Leverage y-yY
Price/Free Cash Flow131y-y EBITDA Growth Rate %-73.8ROA % (ttm)1.1Higher Current Ratio y-yN
Dividend Yield %5.5PEG--ROE % (ttm)11.1Less Shares Outstanding y-yN
Payout Ratio %637Shares Outstanding M4,871ROIC % (ttm)7.7Gross Margin Increase y-yN

Gurus Latest Trades with GLAXF

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

GLAXF is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


GLAXF: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GLAXOSMITHKLINE PLCFormer 10% Owner 2015-02-23Sell503,150$22-3.32view
GLAXOSMITHKLINE PLC10% Owner 2014-12-18Sell50,000$21.140.61view
GLAXOSMITHKLINE PLCFormer 10% Owner (1) 2014-10-27Sell11,315,825$5.29302.08view
GLAXOSMITHKLINE PLC10% Owner 2014-04-01Buy103,762$1277.25view
GLAXOSMITHKLINE PLCFormer 10% Owner 2014-02-19Buy35,000$1451.93view
GLAXOSMITHKLINE PLCFormer 10% Shareholder 2014-02-10Buy143,773$1277.25view

Quarterly/Annual Reports about GLAXF:

    News about GLAXF:

    Articles On GuruFocus.com
    A Closer Look Into Veritas Pharma Apr 21 2016 
    Dividend and Value Opportunities in the Large-Cap Pharmaceutical Space Apr 05 2016 
    Why the UK Is Headed For a Slowdown Mar 23 2016 
    Insiders Roundup: Theravance Biopharma, Western Gas, Upland Software Mar 18 2016 
    Brandes Makes a Variety of Reductions in 4th Quarter Feb 11 2016 
    10 Fund Managers Are Totally Wrong on GlaxoSmithKline Jan 26 2016 
    Stocks Bring High Dividend Yields to HOTCHKIS & WILEY Jan 14 2016 
    Jeff Auxier's Holdings Trading Below Peter Lynch Earnings Line Jan 04 2016 
    Cisco Systems, Microsoft and Intel Bring High Dividend Yields to First Eagle Investment Jan 04 2016 
    High Dividend Yield Ratios Are Hallmarks of Many Dodge & Cox Stakes Dec 21 2015 

    More From Other Websites
    How Did GlaxoSmithKline’s Global Pharmaceuticals Business Perform? May 05 2016
    GSK to sell, lease back, buildings in RTP May 04 2016
    Is GlaxoSmithKline plc about to bomb? May 04 2016
    Why GlaxoSmithKline plc, 3i Group plc and Barratt Developments plc should outperform the FTSE 100! May 04 2016
    How Did GlaxoSmithKline’s Pharmaceutical Segment Perform in 1Q16? May 03 2016
    How Is GlaxoSmithKline’s Growth Trending? May 03 2016
    The numbers don’t lie, GlaxoSmithKline plc is set to beat AstraZeneca plc this year May 03 2016
    GSK CEO: Big pharma should keep investing in R&D May 02 2016
    France gets G7 to discuss global regulation of medicine prices May 02 2016
    France gets G7 to discuss global regulation of medicine prices May 02 2016
    GlaxoSmithKline’s Stock Rose on Solid 1Q16 Earnings Apr 30 2016
    GSK reformulates mouthwash into a gel to prevent infections in newborns Apr 29 2016
    Glaxo's Mouthwash-Inspired Gel for Babies Wins EU Agency Backing Apr 29 2016
    Reformulated GSK mouthwash endorsed as umbilical cord antiseptic Apr 29 2016
    GlaxoSmithKline (GSK) Q1 Earnings Lag, Revenues Up Y/Y Apr 28 2016
    Have income investors forgotten just how good GlaxoSmithKline plc and Vodafone Group plc really are? Apr 28 2016
    Glaxo Finally Finds Some Momentum Apr 27 2016
    Britain's FTSE rises after Glaxo boost Apr 27 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)